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Introduction
The United States dominates sorghum production and distribu-
tion, accounting for 50% of the world’s exports but most of our own 
supply is used as animal feed (1). In addition, >1.3 million metric tons 
of grain sorghum serve as raw material for ethanol per year, yield-
ing 8.2 kg of distiller’s dried grains with solubles (DDG) per 25 kg 
of grain sorghum (GS) (2). These statistics are expected to increase 
throughout the next decade to fulfill the 36 billion gallons per year re-
newable fuel mandate specified in the Renewable Fuels Standard by 
2022 (3). Considering that the coproducts of dry-grind ethanol pro-
duction are also distributed solely as animal feed, alternative appli-
cations for GS and its coproducts are needed to add value to this cur-
rently underutilized cereal.
Recent studies have shown that GS-DDG retains potentially valu-
able lipids at levels approximately 2-fold higher compared to their 
whole kernel counterpart (4). Composition analysis has further shown 
that the crude GS-DDG lipid fraction contains policosanols, alde-
hydes, triacylglycerides, hydrocarbons, tocopherols, phytosterols, free 
fatty acids, diacylglycerides, and vitamin E (2, 4, 5). Many of these lip-
ids are garnering attention due to their potential anticancer proper-
ties. For example, Awad et al. (6) demonstrated that the phytosterol, 
β-sitosterol, decreased in vitro breast cancer growth by 70%, whereas 
campesterol had a weaker effect, reducing cell growth by 6%. Epide-
miology studies completed in Uruguay showed an inverse correla-
tion between stomach cancer and phytosterol consumption (7). Camp-
bell et al. (8) showed that the vitamin E isomer, γ-tocopherol, exerted 
a significant antiproliferation effect on two of the four immortal colon 
cancer lines studied. Evidence linking dietary fatty acids to anticancer 
properties has also been reported. Rats induced with mammary can-
cer but fed a diet high in olive oil had a 10% reduction in tumors com-
pared to a corn oil based diet (9). These results were attributed to the 
high levels of n-3 polyunsaturated fatty acids in olive relative to corn 
oil, which contains higher levels of n-6 polyunsaturated fatty acids.
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Abstract
Antiproliferative properties of lipids extracted from grain sorghum (GS) dry distiller’s grain (DDG) were analyzed to deter-
mine the feasibility of developing GS coproducts as a source for human health dietary ingredients. The lipid extract of GS-
DDG was delivered to human colon carcinoma (Caco-2) cells by solubilizing 0−1000 μg/mL of GS-DDG lipids in 100 μg/mL 
increments with micelles. A significant reduction in cell viability (25−50%) resulted at treatment levels of 400−1000 μg/mL 
GS-DDG lipids (p < 0.05). Alternatively, total protein levels of cells treated with 400, 500, and 600 μg/mL of GS-DDG lipid 
were not significantly different from the control, indicating cell growth during the treatment period. Total cell counts for the 
control were not significantly different from the GS-DDG lipid treated cells, but dead cell counts increased by 10% for the 
latter sample with a concomitant increase of the intercellular protein lactate dehydrogenase leakage (30−40%) in the medium. 
Preliminary analysis by the fluorescence-activated cell method (FACs) demonstrated that nonviable cells were in either the 
early apoptotic, late apoptotic, or necrotic stage post-treatment with 400, 500, and 600 μg/mL GS-DDG lipids. Physiochemical 
characterization of the GS-DDG lipids used for the antiproliferation study showed the presence of vitamin E (predominantly 
γ-tocopherol), triacylglycerides (predominantly linoleic acid), policosanols, aldehydes, and sterols (predominantly campes-
terol and stigmasterol), each of which or as synergistic/additive group of constituents may be responsible for the antiprolif-
erative effect.
Keywords: grain sorghum, antiproliferation, ethanol, dry distiller’s grain, Caco-2 cells
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Studies have yet to be completed that directly link GS-DDG lipids 
to anticancer benefits, but epidemiological data have shown reduced 
risks for gastrointestinal tract based cancers with GS consumption (10-
12). If anticancer agents are also present in the GS-DDG lipid extract, 
it is reasonable to expect that this coproduct can be developed as an 
ingredient source for the niche but fast-growing functional food and 
nutraceutical (FNNs) market. Consumption of such products is in-
creasing to unprecedented levels, particularly in Japan, Europe, and 
the United States due to rising health care costs and aging populations 
(13, 14). The objective of this study was to characterize the antiprolifer-
ation effects on the human cancer colon cell line (Caco-2) in response 
to GS-DDG crude lipid extract. Compositional analysis of the crude 
lipid extract used for this study was also completed to provide prelim-
inary data on the possible agent(s) responsible for eliciting the health-
benefiting responses.
Materials and Methods
Preparation of GS-DDG Lipid Extracts.  A sample of GS-DDG 
was obtained from the U.S. Energy Partners facility located in Russell, 
KS. Lipids were extracted by recirculating 300 mL of hexane heated to 
55 °C over 200 g of GS-DDGs as described by Wang et al. (15). After an 
extraction period of 6 h, the solvent was evaporated under vacuum, 
and the resulting residue was stored at 4−10 °C until needed.
Lipid Solubilization.  Micelles were prepared by combining 
221 mg/mL lecithin with 161 mg/mL cholesterol and transferred in 
0.041−0.048 mL aliquots into vials. GS-DDG lipid samples were dis-
solved in hexane at 40 mg/mL and transferred in 1−10 mg aliquots 
into the lecithin/cholesterol mixture. The samples were dried under 
nitrogen while heating at 50 °C for at least 5 min. Taurcholic acid so-
dium salt (5.4 mg) was added to each vial followed by 10 mL of the 
growth medium, Delbecco′s Modified Eagle Medium (DMEM). The 
samples were sonicated with an S-450D Branson digital sonifier (Dan-
bury, CT) at 30% amplitude for 2−3 min. The solubilized lipids were 
stored at refrigerated temperatures for a maximum of 3 days.
Culture Preparation.  Human colon carcinoma cells (Caco-2) 
(American Type Culture Collection, Manassas, VA) were maintained 
in DMEM supplemented with 20% fetal bovine serum, 1% nonessen-
tial amino acids, 1% l-glutamine, and 50 μg/mL penicillin and strepto-
mycin. The cells were cultured in 75 cm2 collagen-coated culture flasks 
at 37 °C and 5.0% CO2. The cells were passaged with 3 mL of trypsin 
for 5 min after reaching 80% confluency. Tests were conducted at cell 
passage numbers of 30−50.
Cellular Proliferation.  Cell proliferation studies were initially 
completed with 10 treatments of 100−1000 μg/mL solubilized GS-
DDG lipid extracts at 100 μg/mL increments. The cells were harvested 
by release with trypsin, counted with a Neubauer hemocytometer 
(VWR Scientifics, West Chester, PA) under a Microscoptics IV900 se-
ries microscope (VWR Scientifics), and centrifuged at 2900 rpm for 5 
min. The cells were resuspended in DMEM and dispensed in 96-well 
plates at 5 × 104−1 × 105 cells/well. After allowing 24 h for cell recov-
ery at 37 °C in 5.0% CO2, the medium was gently removed from each 
well and the lipid treatments were added. The plates were incubated 
for another 24 h, and percent cell viability was assessed with the tet-
razolium salt 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bro-
mide (MTT) assay according to the manufacturer’s instructions. The 
MTT reagent (10 μL) was added to each well, and the plates were in-
cubated at 37 °C and 5.0% CO2 for another 2 h. The cells were then 
lysed with 100 μL/well of lysis buffer supplied with the MTT kit, fol-
lowed by an additional 4 h of incubation. The absorbance (abs) was 
monitored at 580 and 620 nm with a FLOUstar Optima ELISA plate 
reader (BMG Labtech, Offenberg, Germany). Cell proliferation was 
calculated as % viability = (sample abs/control abs) × 100. Results are 
reported as the percent viability ± standard error of the mean (SEM) 
of six replicates for each treatment (four to six analyses per replicate).
The bicinchonic acid (BCA) protein assay was used to monitor over-
all cell growth in response to different lipid treatments. The cells were 
seeded into 96-well plates (5 × 104 cells/well) and maintained in DMEM 
for 24 h. The medium was removed and replaced with 400, 500, or 600 
μg/mL of the solubilized GS-DDG lipid. The plates were incubated for 
another 24 h, and the medium was carefully removed. Each well was 
washed with 50 μL of phosphate-buffered saline (PBS) followed by an-
other 50 μL of PBS and 100 μL of the MTT lysis buffer. After 1 h of incu-
bation at 37 °C, 50 μL of lysate from each well was transferred to a clean 
well containing 150 μL of PBS. BCA (150 μL) was added to each well fol-
lowed by incubation at 37 °C for 2 h. The absorbance was monitored at 
544 nm, and protein levels were determined against a calibration curve 
generated with bovine serum albumin. Results are reported as the mean 
± SEM of four replicates (three to four analyses per replicate).
Total and precent dead cell counts were determined with the Try-
pan Blue exclusion dye assay as described by Wijeratne et al. with mi-
nor modifications (16). A 100 μL aliquot of the cells from the 12.5 cm2 
flask treated with 400, 500, or 600 μg/mL of micellarized GS-DDG lip-
ids was collected after harvesting with trypsin. Trypan Blue dye (100 
μL) was combined with the cells, and the total numbers of cells and 
of dead cells (stained) were counted on a Neubauer hemocytome-
ter (VWR Scientifics) under a Microscoptics IV900 series microscope 
(VWR Scientifics). Percent dead cells was calculated as (stained cell 
counts/the total cell count) × 100. Total cell counts and percent dead 
cell counts are reported as the mean ± SEM of three replicates (three to 
four analyses per replicate).
A lactate dehydrogenase (LDH) kit was used to determine cellu-
lar membrane damage in response to lipid treatments as outlined by 
the manufacturer with minor modifications. Cells were transferred 
to 12.5 cm2 culture flasks and allowed to recover in untreated DMEM 
for 24 h during incubation at 37 °C and 5.0% carbon dioxide in the at-
mosphere. After recovery, the medium was aspirated from the cells 
and replaced with 400, 500, or 600 μg/mL of solubilized GS-DDG 
lipid, medium + micelles (control), or fresh medium only, medium − 
micelles (blank). After 24 h, 100 μL of medium from each treatment 
group, control, and blank was transferred to a 96-well plate. The LDH 
reagent was mixed with equal volumes of dye solution, substrate, and 
enzyme preparation and added at a volume of 50 μL to each well. The 
plate was incubated at room temperature for 20 min, and the reaction 
was stopped with 15 μL of 1 N HCl. The absorbance was monitored at 
485 and 680 nm with a FLOUstar Optima ELISA plate reader. To de-
termine the total amount of intracellular LDH, the cells from the pre-
vious test were harvested from 12.5 cm2 flasks with trypsin and de-
activated by DMEM. A sample (500 μL) from each of the treatment 
groups, control, and blank was combined with 50 μL of the TOX-7 
lysis buffer and incubated at 37 °C with 5.0% carbon dioxide for 45 
min. Aliquots (100 μL) from each set of cells were plated onto a 96-
well plate in triplicate. The LDH reagent was mixed with equal vol-
umes of the dye solution, substrate, and enzyme preparation, which 
was added at a volume of 50 μL to each well. The plate was incubated 
at room temperature for 20 min followed by deactivation with 15 μL 
of 1 N HCl. The absorbance was monitored at 485 and 680 nm with a 
FLOUstar Optima ELISA plate reader. Percent LDH leakage was cal-
culated by determining the net absorbance of 680 nm from 485 nm ob-
tained from both the supernatant and cell lysis data and applying the 
following relationship: % LDH = (net abs of supernatant/(net abs of 
supernatant + net abs of cell lysate)). Results are reported as the mean 
percent LDH ± SEM of four replicates (three analyses per replicate).
Cellular necrosis and apoptosis in response to lipid treatments of 
400, 500, and 600 μg/mL GS-DDG lipid were assessed by using the 
fluorescence-activated cell (FACs) method (17, 18). After treatment, 
cells were harvested and incubated with propidium iodide and fluo-
rescent isothiocyanate−annexin V for 20−30 min at room temperature. 
The cells were loaded into the cuvette of a flow cytometer (Becton 
Dickinson FACScan, Franklin Lakes, NJ) and monitored at an excita-
tion of 488 nm and an emission wavelength of 525 nm for the fluo-
rescein isothiocyanate−annexin V or 575 nm for the propidium iodide. 
Results are reported as the mean ± standard deviation (SD) of percent 
gated cells for one replicate (two analyses per replicate).
GS-DDG Lipid Characterization.  Simple lipid classes present in 
the extract were initially identified and quantitated using thin layer 
chromatography (TLC). A cocktail of standards containing cholesterol, 
fatty acid methyl esters, d-α-tocopherol acetate, and three polyoxyethyl-
enesorbitan monooleate, octacosanol, monoacylglcyerides of oleic acid, 
1,2-diacylglycerols of oleic acid, 1,3-diacylglcyerides of oleic acid, and 
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triacylglycerides of oleic acid was prepared. The GS-DDG lipid sam-
ple was suspended in hexane at a concentration of 25−30 mg/mL. The 
samples/standards were spotted onto a Whatman silica 60 Å TLC plate 
(60 general purpose, 20 × 20 cm, 250 μm, Maidstone U.K.) using 10 and 
5 μL aliquots. The samples/standards were resolved with hexane, di-
ethyl ether, and acetic acid [85:15:2 (v/v/v)]. The lipids were visualized 
by submerging the plate in 10% cupric sulfate in 8% phosphoric acid 
solution and charring at 165 °C for 10 min. The developed plate was 
scanned with a Kodak Gel Logic 440 Imaging System interfaced to Ko-
dak ID Image Analysis software (Carestream Health, New Haven, CT).
A HPLC (Waters 510; Waters Corp., Milford, MA) equipped with a 
Luna 5 μm silica column (250 mm length, 4.6 mm id; Phenomenex, Tor-
rance, CA) was also used to identify and quantify the several simple 
lipid classes. Detection was accomplished with an Alltech 800 evapora-
tive light scattering detector (Deerfield, IL) operated at 50 °C. The neb-
ulizer gas was nitrogen of industry grade, which was set at a flow pres-
sure of 5.0 bar. Solvents consisting of 100% hexane (mobile phase A) 
and 99.8% hexane, 0.2% acetic acid, and 0.02% methyl tert-butyl ether 
(mobile phase B) set at a flow rate of 1 mL/min were used to separate 
the lipids using the following linear gradient: 0 min, 100% A; 2 min, 
100% A; 3 min, 95% A; 10 min, 95% A; 14 min, 55% A; 15 min, 55% B; 
23 min, 0% A; 26 min, 0% A. The column was heated to 38−40 °C; other 
exposed lines were maintained at 38−40 °C with heating tape. Chro-
matographic bands were identified and quantified with external stan-
dards. Results are expressed as the mean ± SD of a resolved lipid com-
ponent/total GS-DDG lipid (mg/g) of duplicate analyses.
Compositional analysis of the tocopherols was performed with a 
HPLC method described by Bruni et al. (19). In brief, the sample was 
dissolved in hexane at a concentration of 30−40 mg/mL and injected 
onto a silica gel Lichrosorb Si-60 column (Agilent Technologies, Santa 
Clara, CA) interfaced to a Beckman System Gold 127 NM Solvent Mod-
ule HPLC (Beckman Coulter Inc., Fullerton, CA) and heated to 30−32 
°C. Isopropanol (0.05%) in hexane served as the mobile phase, which 
was set at a flow rate of 1 mL/min. Analytes were detected at 295 nm 
with a Beckman System Gold 166 UV−vis detector. The tocopherol 
peaks were identified and quantified by comparison with α-, γ-, and 
δ-tocopherol external standards. Results are expressed as the mean ± SD 
of tocopherols/total GS-DDG lipid (mg/g) of triplicate analyses.
A carotenoid assay was performed with a HPLC method described 
by Craft (20). GS-DDG lipids (2−3 mg) were dissolved in 0.25 mL of 
hexane and then combined with 0.25 mL of methanol. After continual 
shaking for 1 h, the methanol phase was analyzed with a Waters 600 
S HPLC (Milford, MA) system interfaced to a Waters Millennium 32 
Chromatography Manager workstation. The samples were resolved 
using an Agilent Zorbax 300SB C-18 (Santa Clara, CA) column and a 
mobile phase of methanol, acetonitrile, and triethanolamine [90:10:1 
(v/v/v)] under isocratic conditions maintained at a flow rate of 1 mL/
min. A Waters 996 photodiode array set at 450 nm was used as the 
detection mode. Results are not provided as carotenoids were not de-
tected in triplicate analyses of the sample.
Quantification of sterols (free and esterified) was achieved with gas 
chromatography (GC) and flame ionization detection. GS-DDG lipids 
(10−20 mg) were prepared and analyzed according to the method of 
Schnieder et al. (21). The samples were injected (1 μL) onto an HP 5890 
Series II+ GC with a DB-1 column (15 m × 0.25 mm) (J&W Scientific, 
Folsom, CA) under the following conditions: initial temperature, 190 
°C for 1 min, increased to 220 at 3 °C/min; injector temperature, 270 
°C; flame ionization detector temperature, 300 °C; helium carrier gas; 
and split ratio, 20:1. External standards of stigmasterol, campesterol, 
and β-sitosterol were used to identify and quantify the peaks. Results 
are expressed as the mean ± SD of a sterol/GS-DDG lipid (mg/g) of 
triplicate analyses.
Fatty acid profiles were determined by adapting the American 
Oil Chemists’ Society standard method Ce1b-89 (22) as follows. Bo-
ron trifluoride (14%) in methanol was added to a sample and then 
was heated at 100 °C for 30 min in sealed reaction vials. The samples 
were allowed to cool to room temperature before extraction with 1 mL 
of hexane and three rinses of 2 mL of water. The hexane fraction and 
fatty acid standards were resolved with a Hewlett-Packard Co. 6890 
series GC System Plus+ (Wilmington, DE) using a DB-Wax column (30 
m × 0.25 mm) by J&W Scientific and detected with a flame ionization 
detector. Injections were achieved with a split ratio of 10:1 with the 
temperature set at 185 °C initially for 12 min; the temperature was in-
creased to 210 at 10 °C/min, held for 0 min, and then increased to a fi-
nal temperature of 230 at 10 °C/min, which was maintained for the re-
maining 15 min of the run. Results are expressed as the mean ± SD of 
the relative percentage of each fatty acid of triplicate analyses.
Analysis of Data.  Results were analyzed with R:A language and 
environment for statistical computing software (Vienna, Austria) 
and/or by StatsGraphic Plus, version 4 (Statpoint Technologies, Inc., 
Warranton, VA). Cell culture experiments were blocked for plates and 
time. The Cockran C test and Bartlet’s test were performed to deter-
mine whether the variability between treatment results and the con-
trols or from each other was significantly different at the 95% confi-
dence interval (p < 0.05). If not, the Tukey HSD mean separation test 
was completed to determine whether the means from the cell culture 
data were significantly different at the 95% confidence interval (p < 
0.05). Statistical comparisons of the results based on the Tukey HSD 
mean separation test are therefore reported. The final results are ex-
pressed either as the mean ± SEM when three to four replicates were 
completed and each replicate sample was analyzed multiple times or 
as the mean ± SD when a single replicate was analyzed in duplicate or 
triplicate. Potential outliers were assessed with the Grubbs test at a 5% 
risk for rejection.
Results and Discussion
Antiproliferation Study.  The ability of GS-DDG lipids to in-
hibit cancer proliferation was evaluated using the human colon carci-
noma cell line (Caco-2) as colon cancer is the second and fourth lead-
ing cause of cancer death in North America/Europe and worldwide, 
respectively (23-25). Moreover, grain sorghum consumption has been 
shown to be associated with reduced risks for gastrointestinal-based 
cancers (10-12). The antiproliferation properties of GS-DDG lipids 
(100−1000 μg/mL in 100 μg/mL increments) were initially evaluated 
by monitoring the mitochondrial activity of GS-DDG lipid treated 
Caco-2 cells using the MTT assay. Because the GS-DDG samples were 
insoluble in the DMEM medium, micelles prepared with taurcholic 
acid sodium salt, lecithin, and cholesterol were able to solubilize the 
GS-DDG lipid at all treatment levels tested. While micelles have been 
used for delivering cholesterol and other sterols to mammalian cells 
(26), they are unique to a complex lipid extract. The data were thus 
normalized to the control (cells + micelles) as cell proliferation was af-
fected by the micelle delivery system resulting in significantly lower 
percent cell viability compared to the blank (cells − micelles) (data 
not shown). As shown in Figure 1, percent cell viability decreased in 
a dose-dependent manner with significant differences (25−50% reduc-
tion) occurring at treatment levels ≥400 μg/mL. Percent viability was 
not significantly different for cells treated with 400−1000 μg/mL GS-
DDG lipids, indicating a limiting dosage of 400 μg/mL.
The effective antiproliferative treatment levels and/or exposure 
time (24 h) used for this study were lower than reported for several 
other types of natural extracts and/or pure components. For exam-
ple, Yang et al. (27) demonstrated that the polar extracts from differ-
ent varieties of onion reduced Caco-2 proliferation at EC50 values be-
tween 30.5 and 141.1 mg/mL. In addition, Kuntz et al. (28) reported 
that pure phenolic compounds, including different types of flavones, 
flavonols, flavanones, and isoflavones, reduced Caco-2 proliferation at 
EC50 values of 40−200 μM and exposure times of 72 h. Considering 
that a complex lipid extract is not widely recognized as an anticancer 
agent, particularly with respect to polar-based extracts or pure pheno-
lics compounds, these results indicate that the GS-DDG lipids have ef-
fective antiproliferation properties.
The lowest level of GS-DDG lipid extract (100 μg/mL) admin-
istered in this study resulted in significantly lower cell viability, 
whereas cells exposed to dosage levels of 200−300 μg/mL were com-
parable to the control (Figure 1). Other researchers have reported sim-
ilar but atypical responses for cells exposed to low doses of pure nat-
ural agents, that is, cell viability initially increased and then decreased 
or decreased, increased, and decreased again with higher treatment 
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doses (18, 29-31). Darbon and Casagrande (31) attributed their results 
to the ability of biological systems to compensate for low-level toxicity 
of a bioactive agent but are overcome at higher treatment doses. More 
studies are needed to understand this low-dose response as these re-
sults may have important clinical implications. For the purpose of this 
study, higher GS-DDG lipid dosage levels that adversely affected pro-
liferation (400−600 μg/mL) were used for the remaining experiments.
Colon cancer usually presents as hyperproliferation of the epithe-
lial lining due to deregulated cell cycle arrest and/or the suppression 
of programmed cell death (apoptosis) (24, 31). Dietary components 
have in turn been shown to control such abnormal growth by causing 
tumor cell death and/or by regulating the cell cycle (8, 17, 18, 27-34). 
To understand in part the chemoprotective properties of GS-DDG lip-
ids against Caco-2 proliferation, overall cell growth was determined 
by monitoring cellular protein levels prior to and after the 24 h treat-
ment period (Table 1). Protein levels of the control and treated cells 
were significantly higher post-treatment compared to the control pre-
treatment, showing that the cells continued to grow. Considering that 
the control and the treated cells had comparable protein levels, the re-
sults suggest that GS-DDGs did not impact proliferation by inhibiting 
cell growth after 24 h of treatment.
Acute cytotoxic effects of the GS-DDG lipids were assessed by 
measuring percent dead cell counts relative to total cells counts (Table 
2). Total cell counts were not significantly different between the con-
trol and any of the lipid treatments tested (400, 500, and 600 μg/mL 
of GS-DDG lipids), again indicating that the treated cells grew dur-
ing the exposure period. However, the percent dead cells were higher 
for each treatment group compared to the control but were similar be-
tween GS-DDG lipid dosage levels. A loss of cellular membrane integ-
rity in response to each GS-DDG lipid was confirmed with the LDH 
assay. As shown in Figure 2, a significant increase of the cellular pro-
tein, LDH, was detected in the medium for samples treated with the 
GS-DDG lipids, but the LDH level for the 400 μg/mL treated cells was 
significantly lower compared to the 500 and 600 μg/mL doses, which 
may signify greater protection with higher GS-DDG doses. In addi-
tion, LDH levels were not significantly different between the blank 
and the control, indicating that the micelles were not acutely cytotoxic 
to the cells (Figure 2). These results are supported by the cell count 
data (Table 2) as significantly higher total cell counts occurred for the 
blank (cells − micelles) compared to the control (cells + micelles) but 
the percentages of dead cells were similar between the two samples.
Because the dead cell counts accounted for only 10% of total cell 
count (Table 2), but overall viability was reduced by 25−50% as evi-
denced by the MTT results (Figure 1), the presence of apoptotic cells 
was determined by flow cytometry after staining with fluorescent 
isothiocyanate−annexin V (AV) and/or propidium iodide (PI). Cells 
were considered viable, early apoptotic, late apoptotic + necrotic, or 
necrotic for AV−/PI−, and AV+/PI-, AV+/PI+, and AV−/PI+ counts, 
respectively. Viable cell count decreased significantly for each dos-
age level compared to the control (by 12−40%), but the cells treated 
Figure 1. Percent cell viability based on the tetrazolium salt 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT) assay of Caco-2 cells treated 
with grain sorghum dry distiller’s lipids (GS-DDG) (in μg/mL) as compared to the control (0 μg/mL GS-DDG). Results that are significantly different (p < 0.05) 
are designated with different letters from each other, whereas * represents results that are not significantly different (p > 0.05) from the control.
Table 1. Total Protein Levels of Caco-2 Cells before and after 24 h of Treat-
ment with Grain Sorghum Dry Distiller’s Grain Lipids
lipid treatment (μg/mL) total protein levelsa (μg/mL)
0 (control)b 107.5 ± 5.8 a
0 (control)c 151.1 ± 5.0 b
400 154.2 ± 8.0 b
500 145.7 ± 7.2 b
600 145.6 ± 7.4 b
a. Results are expressed as the mean ± standard error of the mean of total 
cellular protein (in μg/mL). Different letters represent results that are sig-
nificantly different (p < 0.05).
b. Represents protein levels of Caco-2 cells before 24 h treatment.
c. Represents protein levels of Caco-2 cells after 24 h treatment.
Table 2. Total and Percent Dead Cell Counts of Caco-2 Cells after 24 h 
Treatment with Grain Sorghum Dry Distiller’s (GS-DDG) Grain Lipids
GS-DDG lipid (μg/mL) total countsa (cells/mL) dead cell countsb (%)
blank 2.27 ± 0.38 × 105 a   6.58 ± 0.61 a
0 (control) 1.14 ± 0.21 × 105 b 16.42 ± 4.89 a
400 9.93 ± 2.05 × 104 b 26.43 ± 4.13 b
500 7.80 ± 1.29 × 104 b 25.62 ± 8.99 b
600 9.35 ± 2.13 × 104 b 26.77 ± 4.35 b
a. Results are expressed as the mean ± standard error of the mean (SEM) 
of total cell counts per mL of medium after staining with Trypan Blue. Dif-
ferent letters in the column represent results that are significantly differ-
ent (p < 0.05).
b. Results are expressed as the mean ± SEM of percent dead cell counts 
after staining with Trypan Blue. Different letters in the column represent 
results that are significantly different (p < 0.05).
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with 400 μg/mL GS-DDG lipids resulted in significantly higher via-
ble counts with respect to the 500 and 600 μg/mL treatments (Figure 
3 and Table 3). These preliminary results support the MTT data (Fig-
ure 1) when accounting for variability inherent to both assays. Simi-
lar to the Trypan Blue and %LDH assays, staining of cells by PI is an 
indicator of the loss of plasma membrane integrity or necrotic cells. 
Although PI-stained cells were apparent by the FACs method (Fig-
ure 3), a population apoptotic cells was also detected after GS-DDG 
lipid treatment at significantly higher numbers compared to the con-
trol with the notable exception of the 400 μg/mL treated cells (Table 
3). These results suggest that the 400 μg/mL dose may not be as effi-
cacious as higher GS-DDG lipid levels as evidenced by the LDH data 
(Figure 2), but the 500 and 600 μg/mL doses resulted in 4−5 times and 
2−7 times more cells in either early apoptotic (AV+/PI−) or necrotic 
(A+/PI+) stages, respectively.
Apoptotic cells exhibit several characteristic morphologic patterns, 
including maintenance of intact plasma membrane and activation of 
surface molecules that target the apoptotic cells for phagocytosis by 
neighboring bodies (35). In contrast, necrotic cells demonstrate cell 
swelling and loss of membrane integrity culminating in the eventual 
release of inflammatory cellular contents. As a result, cancer treatment 
options triggering cell death by apoptosis are preferable to those that 
induce necrosis. It is unclear at this point whether the GS-DDG lipid 
directly induced necrosis or whether apoptotic cells proceeded to sec-
ondary necrosis due to the absence of a phagocytotic response in pure 
cultures. Nonetheless, the cytotoxic effect (caused by a necrotic and/
or an apoptotic response) was probably exhibited late in the 24 h treat-
ment period before the cellular growth rate could be affected. Addi-
tional time course studies are needed to test this hypothesis.
GS-DDG Lipid Characterization Study.  Physiochemical character-
ization of natural systems intended as FFN ingredient sources is needed 
to identify the constituents responsible for their health-promoting prop-
erties. Although other studies have reported the lipid composition of 
GS-DDGs (2, 4, 5), bioactive agents can be affected by extraction con-
ditions, sampling handling, and extended storage periods and are thus 
prone to lot-to-lot variability. Therefore, the crude lipid extract used for 
the previous study was characterized in our laboratory to determine po-
tential bioactive agents responsible for the antiproliferation effect.
Several major simple lipid classes, including triacylglycerides, free 
fatty acids, policosanols, free sterols, and steryl esters, were initially 
detected with TLC, which were confirmed by HPLC-ELSD (data not 
shown). On the basis of the latter test, the most abundant lipid class was 
triacylglycerides (866.0 ± 23.3) followed by free fatty acids (71.0 ± 13) 
(Table 4). Fatty acid compositional analysis showed that these groups 
(in combination the sterol esters) were composed primarily of linoleic 
acid (C18:2) (Figure 4). Despite its being a potential pro-inflammatory 
compound, Sasaki et al. (36) reported that linoleic acid (100−400 μg/
mL) decreased the growth rate of colon cancer cell lines (Colo320 and 
MKN28) by 22−98%. These results correlated with a reduction in tumor 
Figure 2. Percent of total lactate dehydrogenase (LDH) released from 
Caco-2 cells treated with grain sorghum dry distiller’s (GS-DDG) lipids. 
Treatments included a blank, a control (0 μg/mL GS-DDG lipids), and the 
cited treatments of GS-DDG treatments (in μg/mL) solublized in micelles. 
Each treatment was applied for 24 h, and a sample was used to deter-
mine the LDH released from the cells. Results are expressed as the mean 
± standard error of the mean, and those that differ significantly (p < 0.05) 
are designated with different letters.
Figure 3. Fluorescence-activated cell results of Caco-2 cells after 24 h 
treatment with grain sorghum dry distiller’s grain lipids (in μg/mL) (GS-
DDG). Each treatment, including a control (0 μg/mL GS-DDG lipids), was 
applied for 24 h, and a sample was used to determine the percent gated 
counts of cells that stained as annexin V (AV)−/propidium (PI)− (viable), 
AV+/PI− (early apoptotic), AV+/PI+ (late apoptotic + necrotic), or AV−/PI+ 
(necrotic).
Table 3. Fluorescence-Activated Cell Results of Caco-2 Cells after 24 h 
Treatment with Grain Sorghum Dry Distiller’s Grain Lipidsa
lipid treatment    AV−/PI−   AV+/PI−    AV+/PI+ AV−/PI+  
(μg/mL)                  (%)                   (%)                 (%)                    (%)
0 (control) 84.8 ± 1.4 a   1.7 ± 1.4 a   6.8 ± 1.2 a   6.6 ± 0.2 a
400 74.4 ± 1.7 b   2.0 ± 0.6 ab 11.7 ± 2.1 ab 12.1 ± 0.7 a
500 50.2 ± 1.1 c   4.9 ± 0.8 b 28.7 ± 5.0 b 16.1 ± 4.7 a
600 57.1 ± 4.2 c 10.4 ± 1.8 b 30.8 ± 3.1 b 1.65 ± 0.5 a
a. Results expressed as the mean ± standard deviation of percent gated 
events of cells that stained as annexin V (AV)−/propidium (PI)− (viable 
cells), AV+/PI− (early apoptotic cells), AV+/PI+ (late apoptotic + necrotic 
cells), or AV−PI+ (necrotic cells). Different letters in a column represent 
results that are significantly different (p < 0.05).
Table 4. Levels of Simple Lipid Classes in Grain Sorghum Dry Distiller’s 
Grain Lipids
lipid class         amounta (mg/g)
diacylglyceridesb                detectede
sterols (free and esterified) 9.9 ± 1.3
tocopherolsc 0.4 ± 0.0
aldehydes and wax estersd 16.0 ± 11.0
free fatty acidsd 71.0 ± 13.0
policosanolsd 39.0 ± 7.7
triacylglyceridesd 866.0 ± 23.3
hydrocarbonsd                detectedf
a. Results are expressed as the mean ± standard deviation of mg of lipid 
class per gram of lipid.
b. Thin layer chromatography and densitometry.
c. High-performance liquid chromatography with ultraviolet detection.
d. Gas chromatography with a flame ionization detection.
d. High-performance liquid chromatography with evaporative light scatter-
ing detection.
e. Limit of quantitation (0.5 mg/g).
f. Limit of quantitation (0.8 mg/g).
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development when treated and untreated Colo320 and MKN28 cells 
were injected into the peritoneal cavity of BALB/c nu/nu athymic mice. 
The GS-DDG lipid extract also contained relatively high levels of oleic 
acid (C18:1) (Figure 4), which has been shown to be a potential antipro-
liferative agent, albeit against breast cancer (37).
Moreover, GC analysis showed that the phytosterols (free and es-
terified) accounted for 9.9 ± 1.3 mg/g of the lipid extract (Table 4) with 
β-sitosterol and stigmasterol present at equivalent levels followed by 
campesterol (Table 5). Awad and Fink (38) reported that β-sitosterol, 
and possibly stigmasterol and campesterol, increased apoptotic activ-
ity in cancer cells. On the basis of the results cited (Table 5) and the GS-
DDG lipid treatment levels used for this study, the β-sitosterol doses 
delivered to the cells were significantly lower (1−10 nM β-sitosterol) 
than the 30−60 μM 7-hydroxysitosterol required to induce apoptosis 
in Caco-2 cells as reported by Roussi et al. (39).
As previously discussed, Campbell et al. (8) studied the antipro-
liferation effects of tocopherols against several colon cancer cell lines 
(SW480, HCT-15, HCT-116, and HT-29) at levels representing dietary 
and supplementation levels of 25−200 μM, respectively. α-Tocopherol 
did not significantly affect cell proliferation, whereas the lowest dos-
age of γ-tocopherol resulted in the higher dead counts of SW480 and 
HCT-116 cells. Analysis of the GS-DDG lipid extract did show the 
presence of α-tocopherol (0.20 ± 0.00 mg/g) and γ-tocopherol (0.19 
± 0.01 mg/g) at a total concentration of 0.39 ± 0.01 mg/g (Table 4). 
Therefore, the levels of α- and γ-tocopherol in the 1000 μg/mL lipid 
treatment group were each <0.5 nM, that is, again substantially lower 
than the effective doses reported in the literature.
Because preliminary data obtained in our laboratory demonstrated 
that other GS-DDG lipid extracts contained carotenoids, particularly 
β-carotene (data not shown), the sample used for this study was tested 
accordingly. As potent antioxidants, carotenoids can deactivate free 
radicals that damage the basic structure of cells and thus lead to can-
cer (40). However, carotenoids were not detected in the GS-DDG lipid 
sample under the conditions of the test and thus could not account for 
the cited antiproliferation results. These compounds may have been 
lost during processing or may not be present in the GS cultivar that 
served as the raw material.
Other lipid components were detected in the GS-DDG lipid sam-
ple that to our knowledge have yet to be evaluated for their antican-
cer properties. For example, total levels of policosanols accounted 
for 39.0 ± 7.7 mg/g of the extract (Table 4). Compositional analysis of 
their chain lengths was not completed in our laboratory, but Hwang 
et al. (4) confirmed that the wax fraction of GS-DDG was composed 
of C28 and C30 chain policosanols, which is most likely the compo-
sitional profile of the sample used in this study. In addition, two un-
known bands were detected via the TLC method. Hwang et al. (41) 
reported similar TLC banding patterns for lipids extracted from the 
GS whole kernel and confirmed that a band with the same Rf value as 
one of the unknown GS-DDG lipid groups was due to long-chain al-
dehydes. Moreover, Hwang et al. reported that long-chain aldehydes 
accounted for 23% of the wax fraction isolated from GS-DDG sam-
ples (4). Additionally, in-house analysis with HPLC-ELSD showed 
an intense band at the same retention time as the external aldehyde 
standard, albeit wax/steryl esters also coeluted with the former lipid 
group (data not shown). More tests are needed to definitely identify 
the suspect TLC band, but the combined information suggests that it 
may be due to long-chain aldehydes. The other unknown TLC band 
has yet to be identified by our laboratory or by any other published re-
ports. Diacylglycerides and hydrocarbons were further detected in the 
extract but at levels lower than the quantitation capability of the as-
say (Table 4).
In summary, the physiochemical characterization study confirmed 
that the sample contained lipid-based constituents that have been 
linked to potent anticancer properties, but many were significantly be-
low the effective concentrations reported in the literature with the no-
table exception of linolenic and oleic acid. The antiproliferation ben-
efits of the GS-DDG extracts could be caused by synergistic and/or 
additive effects of the components as has been reported for many 
types of natural systems (42-44). The GS-DDG lipid extract also con-
tains other types of lipids that have not been studied for their anti-
proliferation properties but may indeed be potent cancer prevention 
agents. Nonetheless, this project is significant as it is the first to report 
the chemoprotective potential of the GS-DDG lipid extract. Additional 
studies are needed to further elucidate the mechanisms by which GS-
DDG lipids exert their antiproliferation properties against multiple 
types of cancers and to identify the specific component or combination 
of components responsible in order to develop this currently under-
utilized cereal and its coproducts as safe and effective source of ingre-
dients for functional foods.
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